Molecular Targets in Alzheimer’s Disease

被引:0
|
作者
Geir Bjørklund
Jan Aaseth
Maryam Dadar
Salvatore Chirumbolo
机构
[1] Council for Nutritional and Environmental Medicine,Faculty of Health and Social Science
[2] Inland Norway University of Applied Sciences,Department of Research
[3] Innlandet Hospital Trust,Agricultural Research, Education and Extension Organization (AREEO)
[4] Razi Vaccine and Serum Research Institute,Department of Neurosciences, Biomedicine and Movement Sciences
[5] University of Verona,undefined
来源
Molecular Neurobiology | 2019年 / 56卷
关键词
Alzheimer’s disease; Amyloid beta; Tau protein; Oxidative stress;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is known as a devastating neurodegenerative disorder in aged subjects, which is related to multiple heterogeneous genetic factors. The two basic pathological aspects of AD are related to amyloid beta (Aβ) peptides and tau proteins. Some researchers have demonstrated plaques and tangles as apparently primary lesions. Also, experimental data propose that these two lesions are intimately related. In the present review, we highlight some molecular mechanisms linking tau and Aβ toxicities involving oxidative stress, aging, Aβ turnover, the contribution of thiol groups, and the role mitochondrial activities in the AD pathogenesis. Understanding the interplay of these mechanisms as parts of common pathophysiological pathways could reveal molecular targets to control or even treat AD.
引用
收藏
页码:7032 / 7044
页数:12
相关论文
共 50 条
  • [31] Alzheimer's Disease and Cancer: Common Targets
    Yang, Xueqing
    Dai, Jinlian
    Wu, Chenglong
    Liu, Zongliang
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (10) : 983 - 1000
  • [32] Retinoids as potential targets for Alzheimer's disease
    Sodhi, Rupinder K.
    Singh, Nirmal
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 120 : 117 - 123
  • [33] Tropisetron and its targets in Alzheimer's disease
    Hashimoto, Kenji
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (01) : 1 - 5
  • [34] Metal and inflammatory targets for Alzheimer's disease
    Rogers, JT
    Lahiri, DK
    [J]. CURRENT DRUG TARGETS, 2004, 5 (06) : 535 - 551
  • [35] Alzheimer's Disease: Targets For Drug Development
    Larner, A. J.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (01) : 3 - 11
  • [36] New kinase targets for Alzheimer's disease
    Monica Hoyos Flight
    [J]. Nature Reviews Drug Discovery, 2013, 12 : 739 - 739
  • [37] Druggable targets for the immunopathy of Alzheimer's disease
    Weaver, Donald F.
    [J]. RSC MEDICINAL CHEMISTRY, 2023, 14 (09): : 1645 - 1661
  • [38] Possible treatment targets in Alzheimer’s disease
    A. Pryce Roberts
    N. P. Robertson
    [J]. Journal of Neurology, 2013, 260 (12) : 3193 - 3196
  • [39] Peptides as drug targets for Alzheimer's disease
    Gozes, I
    Spier, AD
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 344 - 344
  • [40] Therapeutic targets in the biology of Alzheimer's disease
    Bush, AI
    [J]. CURRENT OPINION IN PSYCHIATRY, 2001, 14 (04) : 341 - 348